Recent Press Releases

UTMB study finds that most patients do not use inhalers and epinephrine autoinjectors correctly

December 9, 2014 For people with asthma or severe allergies, medical devices like inhalers and epinephrine autoinjectors, such as EpiPen, can be lifesaving. However, a new study by the University of...

Run Deep: Pulsing Magnetic Fields Focus Nano-Particles to Deep Targets

December 9, 2014 College Park, Md. – Recent efforts between the University of Maryland (UMD) and Bethesda-based Weinberg Medical Physics LLC (WMP) have led to a new technique to magnetically...

Microchips Biotech, Inc. Completes Development and Clinical Demonstration of Proprietary Drug Delivery Platform and Advances Commercialization Efforts in Diabetes, Contraception and Osteoporosis

December 15, 2014 09:00 AM Eastern Standard Time WALTHAM, Mass.--()--Microchips Biotech, Inc., formerly MicroCHIPS, Inc., today announced the completion of the development and clinical...

Alnylam Introduces Pipeline Growth Strategy for RNAi Therapeutics in Three Strategic Therapeutic Areas, or "STArs"

12.12.2014 - Expands Efforts on Pipeline Development and Commercialization in Genetic Medicine, Cardio-Metabolic Disease, and Hepatic Infectious Disease STArs - - Announces Updated Guidance to File...

MIT Spinoff Receives NSF Grant to Develop Nanoparticle Glaucoma Therapy

December 3, 2014 - Arlington, MA LayerBio is an MIT spin-off developing novel drug delivery products for ophthalmology and wound care applications. The National Science Foundation (NSF) has awarded...

Enteris BioPharma's Formulation Technology Enables Oral Delivery of Cara Therapeutics' CR845 Peptide for Acute and Chronic Pain in Phase 1a / 1b Trial

Cara Therapeutics reported that all tested tablet strengths of Oral CR845 were pharmacologically active, safe and well tolerated after single and multiple dose administration BOONTON, NJ, USA I...

Marina Biotech Reports That Licensee ProNAi Therapeutics Presented Interim Phase 2 Data on Its BCL2-Targeting DNAi(R) Therapeutic at ASH 2014

SMARTICLES(R) Formulated PNT2258 Achieved Meaningful Therapeutic Outcomes Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare...

Insys Therapeutics Receives FDA Orphan Drug Designation for Liposome Entrapped Paclitaxel as a Potential Treatment for Gastric Cancer

PHOENIX, AZ -- (Marketwired) -- 12/09/14 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery...

Injectable 3D vaccines could fight cancer and infectious diseases

(BOSTON/CAMBRIDGE) — One of the reasons cancer is so deadly is that it can evade attack from the body's immune system, which allows tumors to flourish and spread. Scientists can try to...

Unilife Signs Long-Term Commercial Supply Agreement for Use of Depot-ject™ Delivery System with Approved Ocular Injection Drug

YORK, Pa., Dec. 2, 2014 /PRNewswire/ -- Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer and supplier of injectable drug delivery systems, announced today the signing of a worldwide 10...

Oramed Closes $5 Million Investment From Guangxi Wuzhou Pharmaceutical Company

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a developer of oral drug delivery systems, today announced that it has received$5 million in connection with the definitive agreement with Guangxi Wuzhou...

Hovione Files its First Investigational New Drug Application With the FDA

CORK, Ireland, November 27, 2014 /PRNewswire/ -- Hovione announced today it has filed its first Investigational New Drug (IND) Application with the U.S. Food and Drug Administration (FDA). This event...

NuvOx Pharma Receives Exclusive License from University of Arkansas

NuvOx Pharma exclusively licensed United States Patent Application 20140004099 entitled "DODECAFLUOROPENTANE EMULSION AS A STROKE AND ISCHEMIA THERAPY" from the University of Arkansas for Medical...

New NIH funding to help researchers develop drug delivery system to prevent HIV infection in women

The University of Texas Medical Branch is part of a collaboration led by the Oak Crest Institute of Science that received a $20 million grant from the National Institutes of Health to develop a novel...

Catalent And Valerion Therapeutics Collaborate To Bring New Treatments For Orphan Genetic Disorders To Market

Somerset, N.J. – December 2, 2014 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer...

US Army Adopts and Deploys Provodine® from Microdermis to Fight Ebola

PRINCETON, N.J.--()--Microdermis Corporation, a privately held life sciences company, announced today that its new antiseptic product, Provodine®, which incorporates a novel...

Flamel Technologies Sells Development and Manufacturing Facility in Pessac, France to Recipharm AB

LYON, FRANCE--(Marketwired - Nov 28, 2014) - Flamel Technologies (NASDAQ: FLML) announced today that it has entered into an agreement to divest its development and manufacturing facility located in...

OncoSec Medical and Plexxikon Collaborate to Explore Combination Immunotherapy in Preclinical Tumor Studies

SAN DIEGO-- OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced a preclinical collaboration with Plexxikon Inc., a member of the...

OncoSec Medical and the University of Washington Enter Sponsored Research Agreement

Research Will Evaluate Immunological Mechanisms of Intratumoral DNA IL-12 Electroporation SAN DIEGO--OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer...

UC San Francisco and OncoSec Medical Collaborate to Evaluate Investigational Combination of ImmunoPulse and Anti-PD-1 Treatment

Investigator Sponsored Trial Led by Dr. Alain Algazi and Supported by OncoSec and Merck Will Evaluate Combination of KEYTRUDA® and ImmunoPulse in Metastatic Melanoma SAN DIEGO-- OncoSec Medical...